BSB administered after IBD induction significantly (p < 0.05, n = 6) increased mean colonic SOD activity from 0.08 ± 0.01 to 0.15 ± 0.03 u/mg of protein on day 2 of IBD, but significantly (p > 0.001) decreased from 0.17 ± 0.00 to 0.14 ± 0.01 u/mg of protein on day 7. Here, SOD1 is linked to inflammatory bowel disease.